ODI Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2019 - 2020
Net Income	-5.88	-0.57	-6.9	-7.24	-3.98	Upgrade
Depreciation & Amortization	0	0	0	0.01	0.01	Upgrade
Asset Writedown & Restructuring Costs	-0	0	-	-	-	Upgrade
Other Operating Activities	0.05	0.1	0.91	0.04	-0.47	Upgrade
Change in Accounts Receivable	7.83	-8.7	0.33	-0.35	-0.67	Upgrade
Change in Inventory	-	0.81	0.24	-0.49	-1.05	Upgrade
Change in Other Net Operating Assets	-7.37	4.53	0.31	0.65	0.1	Upgrade
Operating Cash Flow	-5.37	-3.82	-5.1	-7.37	-6.06	Upgrade
Capital Expenditures	-	-	-	-0	-	Upgrade
Investing Cash Flow	-	-	-	-0	-	Upgrade
Long-Term Debt Issued	-	-	4.06	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	4.06	-	-	Upgrade
Issuance of Common Stock	4.24	-	-	-	-	Upgrade
Other Financing Activities	-	-	-	-	0.26	Upgrade
Financing Cash Flow	4.24	-	4.06	-	0.26	Upgrade
Foreign Exchange Rate Adjustments	-0.05	-0.02	0.16	0.12	-0.09	Upgrade
Miscellaneous Cash Flow Adjustments	-	-0	-0	-	-	Upgrade
Net Cash Flow	-1.18	-3.85	-0.87	-7.26	-5.89	Upgrade
Free Cash Flow	-5.37	-3.82	-5.1	-7.38	-6.06	Upgrade
Free Cash Flow Margin	-172.75%	-17.16%	-3659.83%	-2357.80%	-	Upgrade
Free Cash Flow Per Share	-0.29	-0.25	-0.33	-0.49	-0.40	Upgrade
Cash Interest Paid	0.68	0.76	0.08	0	0.01	Upgrade
Cash Income Tax Paid	-0.09	0.09	-0.17	0.03	0.52	Upgrade
Levered Free Cash Flow	-3.71	-3.54	1.5	-4.75	-4.6	Upgrade
Unlevered Free Cash Flow	-3.24	-3.01	1.57	-4.73	-4.59	Upgrade
Change in Working Capital	0.46	-3.36	0.88	-0.18	-1.62	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.